Evolution of the Average Target: Glenmark Pharmaceuticals Limited

Evolution of the Target Price: Glenmark Pharmaceuticals Limited

Changes in Analyst Recommendations: Glenmark Pharmaceuticals Limited

f79a3.5AQA6vZ5vUDzIYmbm7UXzTSC7MiG4GSy2Ndv4KHr6hY.vVIxopA3zBOZbe7a1ttkoBngu5_Arx3F6ptXj_CG0kCHXHbeuCCKNb1AxA~4f70b661d3923dddcdc544d37a45ce29

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.39%
+6.17%
+15.33%
+2.65%
-4.96%
-7.03%
+2.62%
+6.96%
- - -
-0.16%
Average +3.44%
Weighted average by Cap. +6.25%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
2,282.90INR
Average target price
2,497.27INR
Spread / Average Target
+9.39%
High Price Target
2,750.00INR
Spread / Highest target
+20.46%
Low Price Target
2,100.00INR
Spread / Lowest Target
-8.01%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Nomura
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
2,282.90INR
Average target price
2,497.27INR
Spread / Average Target
+9.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLENMARK Stock
  4. Consensus Glenmark Pharmaceuticals Limited